TW201436818A - Astragalus membranaceus (Fisch.) Bge. wall-breaking dosage form - Google Patents

Astragalus membranaceus (Fisch.) Bge. wall-breaking dosage form Download PDF

Info

Publication number
TW201436818A
TW201436818A TW103110194A TW103110194A TW201436818A TW 201436818 A TW201436818 A TW 201436818A TW 103110194 A TW103110194 A TW 103110194A TW 103110194 A TW103110194 A TW 103110194A TW 201436818 A TW201436818 A TW 201436818A
Authority
TW
Taiwan
Prior art keywords
ethanol
ultrafine powder
water solution
ratio
weight
Prior art date
Application number
TW103110194A
Other languages
Chinese (zh)
Other versions
TWI531387B (en
Inventor
jin-le Cheng
Zhi-Tian Lai
xue-liang Liang
Yong-Jun Chen
Wei-Lin Qiao
Original Assignee
Zhongshan zhongzhi pharmaceutical group co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongshan zhongzhi pharmaceutical group co ltd filed Critical Zhongshan zhongzhi pharmaceutical group co ltd
Publication of TW201436818A publication Critical patent/TW201436818A/en
Application granted granted Critical
Publication of TWI531387B publication Critical patent/TWI531387B/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a Chinese medicine dosage form and relates specifically to an Astragalus membranaceus (Fisch.) Bge. wall-breaking dosage form. The present invention pulverizes Astragalus membranaceus (Fisch.) Bge. into ultrafine powder, which is subjected to an alcohol-water wetting process to be granulated, extrusion formed under a predetermined rotational speed and then dried. The Astragalus membranaceus (Fisch.) Bge. wall-breaking dosage form so manufactured has an increased bioavailability and the dosage form has improved stability and good disintegrability. The Astragalus membranaceus (Fisch.) Bge. wall-breaking dosage form is characterized in that Astragalus membranaceus (Fisch.) Bge. is subjected to wall-breaking pulverization to obtain ultrafine powder that is added with alcohol-water solution to form a soft material and is subjected to extrusion to form wet granules, which are then dried to form the Astragalus membranaceus (Fisch.) Bge. dosage form. The particle sizes of 90% or more of the ultrafine powder are less than or equal to 45 <mu>m.

Description

一種黃芪破壁製劑 Astragalus breaking preparation

本發明涉及中醫藥領域,更具體地,涉及一種黃芪破壁製劑。 The invention relates to the field of traditional Chinese medicine, and more particularly to a yellow sputum breaking preparation.

超微粉碎技術是近年來迅速發展的一項新技術。中藥材中的有效成分大多分佈在細胞內,常規飲片煎煮時只能使部分有效成分釋放出來,有效成分利用率10-30%;而採用破壁粉碎技術,如將中藥飲片粉碎至300目左右,細胞破壁率將達到86.7%,提高了藥材中有效成分的溶出,大大增強其藥效,有效成分利用率在90%以上,達到減少藥材使用量及保護藥材資源,同時還可提高藥品的品質增加藥效。但是,目前的主要超微粉技術仍停留在將中藥材粉碎至超細製劑的階段。由於超細製劑細胞破壁率增加,存在破壁製劑表面積增大,形狀不規則,流動性、分散性差,易於吸濕,穩定性差等固有特點,將其製粒,提高產品的穩定性,本發明製備的製劑很好的解決了以上存在的問題,達到藥材的利用及使用最大化。 Superfine pulverization technology is a new technology that has developed rapidly in recent years. Most of the active ingredients in Chinese herbal medicines are distributed in the cells. When the conventional decoction pieces are boiled, only some of the active ingredients can be released, and the effective ingredient utilization rate is 10-30%; and the broken wall crushing technology, such as the Chinese medicine decoction pieces, is crushed to 300 mesh. Left and right, the cell wall breaking rate will reach 86.7%, which improves the dissolution of the active ingredients in the medicinal materials, greatly enhances its efficacy, and the utilization rate of the active ingredients is above 90%, thereby reducing the amount of medicinal materials used and protecting the medicinal materials, and also improving the medicines. The quality of the product increases the efficacy. However, the current main ultrafine powder technology still stays at the stage of pulverizing Chinese herbal medicines to ultrafine preparations. Due to the increased cell wall breaking rate of the ultrafine preparation, the surface area of the broken wall preparation is increased, the shape is irregular, the fluidity, the dispersibility is poor, the moisture absorption is easy, and the stability is poor, and the granulation is performed to improve the stability of the product. The preparation prepared by the invention solves the above problems well and maximizes the utilization and use of the medicine.

目前,對於破壁製劑及其製粒過程中存在以下的技術難題:(1)目前的破壁製劑儘管中藥成分的利用率高,但破壁粉體易於被氧化,穩定性不高,藥效容易喪失;(2)已有的中藥品種通過軟材製粒獲得的產品,很難同時保證收率、崩解性和穩定性;(3)有些中藥品種是不適宜採用破壁粉體-軟材製粒法製成製劑的,如枸杞、懷牛膝之類;而本發明通過大量實驗性的摸索,將適宜破壁粉體-軟材製粒法的中藥品種篩選出來,並且摸索出各步驟的條件。 At present, the following technical problems exist in the broken wall preparation and its granulation process: (1) The current broken wall preparation is easy to be oxidized due to high utilization rate of traditional Chinese medicine ingredients, and the stability is not high, and the efficacy is low. It is easy to lose; (2) It is difficult to ensure the yield, disintegration and stability of the traditional Chinese medicine varieties obtained by soft material granulation; (3) Some Chinese medicine varieties are not suitable for using broken wall powder-soft The granulation method is prepared into a preparation, such as scorpion, achyranthes and the like; and the invention screens out the traditional Chinese medicine varieties suitable for the broken wall powder-soft material granulation method through a large number of experimental groping, and explores each The conditions of the steps.

黃芪為為豆科植物蒙古黃芪Astragalus membranaceus(Fisch.)Bge.var.mongholicus(Bge.)Hsiao或膜莢黃芪Astragalus membranaceus(Fisch.)Bge.的乾燥根。主要含三萜皂苷類成分:黃芪皂苷I、Ⅱ、Ⅲ、Ⅳ(黃芪甲苷),大豆皂苷I,莢膜黃芪苷I、Ⅱ等;黃酮類成分:芒柄花素,毛蕊異黃酮葡萄糖苷等;還含多糖、氨基酸等。採用傳統的煎煮方法,容易破壞其熱敏性成分,另一方面有效成分煎煮不完全,造成有效成分的流失。將黃芪製備成黃芪超細粉體,有利於提高有效成分的利用率,但同時由於粉體比表面積的增加,產生易於吸潮、氧化、變質等的缺點。因此,在製備成超細粉體的基礎上,還需要對其進行進一步的加工改造,以有效克服這些不利因素,最大化的發揮藥物的治療效果。 Astragalus is the dried root of the leguminous Astragalus membranaceus (Fisch.) Bge.var.mongholicus (Bge.) Hsiao or Astragalus membranaceus (Fisch.) Bge. It mainly contains triterpenoid saponins: astragaloside I, II, III, IV (xanthine), soy saponin I, capsular baicalin I, II, etc.; flavonoids: formononetin, flavonoids, glucose Glycosides and the like; also contains polysaccharides, amino acids and the like. The traditional decoction method is easy to destroy the heat-sensitive component, and on the other hand, the active ingredient is not fully boiled, resulting in the loss of the active ingredient. The preparation of astragalus ultrafine powder is beneficial to increase the utilization rate of the active ingredient, but at the same time, due to the increase of the specific surface area of the powder, it has the disadvantages of easy moisture absorption, oxidation, deterioration and the like. Therefore, on the basis of preparation of ultrafine powder, it is necessary to further process and modify it to effectively overcome these unfavorable factors and maximize the therapeutic effect of the drug.

本發明所要解決的技術問題是,為了克服黃芪破壁粉體存在的上述不足,提供一種黃芪破壁製劑。 The technical problem to be solved by the present invention is to provide a yellow scorpion broken wall preparation in order to overcome the above-mentioned deficiencies of the scutellaria broken powder.

本發明所要解決的上述技術問題通過以下技術方案予以實現:本發明提供的一種黃芪破壁製劑,採用如下的技術方案:將黃芪進行破壁粉碎獲得超細粉體,加入乙醇-水溶液充分混合,製得軟材,再進一步擠壓獲得濕粒,乾燥獲得黃芪破壁製劑;所述超細粉體中90%或以上的顆粒粒徑小於等於45μm。 The above technical problem to be solved by the present invention is achieved by the following technical solution: the invention provides a yellow scorpion broken wall preparation, which adopts the following technical scheme: the scutellaria is subjected to wall pulverization to obtain an ultrafine powder, and the ethanol-water solution is added and thoroughly mixed. The soft material is obtained, further extruded to obtain wet granules, and dried to obtain a scutellaria broken-wall preparation; 90% or more of the ultrafine powder has a particle diameter of 45 μm or less.

本發明製備的黃芪破壁製劑,可以使得消費者在服用時不經煎煮,通過用溫開水沖服即可使得有效成分的利用最大化。 The yellow scorpion broken wall preparation prepared by the invention can make the consumption of the active ingredient maximized by the consumer without decocting by washing with warm water.

可以將黃芪先粉碎至100目,再進一步進行超微粉碎,使得超細粉體中90%或以上(比如可以是90%、91%、92%、93%、94%或95%)的顆粒粒徑小於等於45μm。本發明中採用的超細粉體,90%的顆粒粒徑將近為 45μm的粉體,以35~45μm為多(比如可以為35、36、37、38、39、40、41、41、42、43、44或45μm),但只要是粒徑小於等於45μm均可實現本發明。 The scutellaria can be first pulverized to 100 mesh and further subjected to ultrafine pulverization so that 90% or more of the ultrafine powder (for example, 90%, 91%, 92%, 93%, 94% or 95%) may be granulated. The particle size is less than or equal to 45 μm. The ultrafine powder used in the present invention, 90% of the particle size is nearly 45μm powder, more than 35~45μm (such as 35, 36, 37, 38, 39, 40, 41, 41, 42, 43, 44 or 45μm), but as long as the particle size is less than or equal to 45μm The present invention has been achieved.

優選地,所述的超細粉體的破壁率為80~95%。 Preferably, the ultrafine powder has a wall breaking rate of 80 to 95%.

本發明採用乙醇-水溶液進行濕法製粒,其突出的優點在於不需要任何其他添加劑,即可使得本發明的超細粉體通過後續的製粒、乾燥,成為黃芪製劑顆粒。但在該過程中,應該採用何種濃度的乙醇-水溶液,以及該溶液與超細粉體之間的配比,都是需要嚴格控制的參數,以使得軟材的濕度、固含量、黏度等可適用於黃芪破壁製劑的特性,使製劑之間可有效黏結;進一步通過特定的擠壓參數的設定,將軟材擠壓成為密度、大小合適的黃芪顆粒製劑,使其密度/蓬鬆度適當,由此在乾燥成為成品之後,即使放置於室溫空氣中,也可以防止空氣的氧化作用。並且,所獲得的成品,在用溫開水沖服時,超細製劑可以較為迅速地散開,使得有效成分迅速而充分地溶解和擴散,提高有效成分利用率。 The present invention employs an ethanol-water solution for wet granulation, which has the outstanding advantage that the ultrafine powder of the present invention can be subjected to subsequent granulation and drying to form scutellaria preparation granules without any other additives. However, in the process, what concentration of ethanol-water solution should be used, and the ratio between the solution and the ultrafine powder are parameters that need to be strictly controlled to make the moisture, solid content, viscosity, etc. of the soft material. It can be applied to the characteristics of the scutellariae breaking preparation, so that the preparation can be effectively bonded; further, through the setting of specific extrusion parameters, the soft material is extruded into a suitable density and size of the scutellaria granule preparation to make the density/fluffiness appropriate. Therefore, after drying into a finished product, even if it is placed in air at room temperature, the oxidation of air can be prevented. Moreover, when the finished product obtained is washed with warm water, the ultrafine preparation can be dispersed relatively quickly, so that the active ingredient dissolves and diffuses rapidly and fully, and the utilization ratio of the active ingredient is improved.

本發明通過多次摸索,最終選取了如下的方案:濕法製粒時,所採用的乙醇-水溶液中乙醇的品質分數為20%~80%;優選的,乙醇的品質分數為30%~70%,更優選的為45%~65%。當乙醇品質分數為20%~29%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~0.65,優選為1:0.6;當乙醇品質分數為30%~39%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~0.9,優選為1:0.6~0.65;當乙醇品質分數為40%~49%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~1.0,優選為1:0.6~0.7;當乙醇品質分數為50%~59%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~1.1,優選為1:0.6~0.8;當乙醇品質分數為60%~69%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~1.2,優選為1:0.8~1.0,當乙醇品質分數 為70%~80%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~1.3,優選為1:0.8~1.1。 The invention has repeatedly selected the following schemes: in the wet granulation, the ethanol component in the ethanol-water solution has a quality fraction of 20% to 80%; preferably, the ethanol quality fraction is 30% to 70%. More preferably, it is 45% to 65%. When the ethanol quality fraction is 20% to 29%, the ratio of ultrafine powder to ethanol-water solution is 1:0.6~0.65, preferably 1:0.6; when the ethanol quality fraction is 30%~39%, super The ratio of the fine powder to the ethanol-water solution is 1:0.6 to 0.9, preferably 1:0.6 to 0.65; when the ethanol quality fraction is 40% to 49%, the ratio of the ultrafine powder to the ethanol-water solution is by weight. It is 1:0.6~1.0, preferably 1:0.6~0.7; when the ethanol quality fraction is 50%~59%, the ratio of ultrafine powder to ethanol-water solution is 1:0.6~1.1 by weight, preferably 1: 0.6~0.8; when the ethanol quality fraction is 60%~69%, the ratio of ultrafine powder to ethanol-water solution is 1:0.6~1.2, preferably 1:0.8~1.0 by weight, when the ethanol quality score is When it is 70% to 80%, the ratio of the ultrafine powder to the ethanol-water solution is 1:0.6 to 1.3 by weight, preferably 1:0.8 to 1.1.

在將軟材擠壓成為濕粒時,優選控制在以下條件:採用預裝10目~30目篩網,擠壓力度0.05Mpa~1Mpa,轉速50r/min~100r/min;優選的,擠壓力度0.7Mpa~0.8Mpa,轉速55r/min~65r/min。 When the soft material is extruded into wet granules, it is preferably controlled under the following conditions: a pre-packed 10 mesh to 30 mesh screen, a pressing force of 0.05 MPa to 1 MPa, a rotational speed of 50 r/min to 100 r/min; preferably, extrusion The strength is 0.7Mpa~0.8Mpa, and the speed is 55r/min~65r/min.

擠壓所得的濕粒粒徑為14目~30目,乾燥時乾燥溫度為45℃~85℃,乾燥時間為0.5h~4.0h。 The wet particle size obtained by extrusion is 14 mesh to 30 mesh, the drying temperature during drying is 45 ° C to 85 ° C, and the drying time is 0.5 h to 4.0 h.

所獲得的黃芪破壁製劑的堆密度為0.30g/ml~0.65g/ml。 The bulk density of the obtained scutellariae breaking preparation was 0.30 g/ml to 0.65 g/ml.

與現有技術相比,本發明具有以下有益效果:(1)通過本發明的方法獲得的黃芪製劑,其有效成分利用率大大提高,利用率接近於100%;經生物等效試驗證實,採用1/4份的黃芪破壁製劑即可相當於1份傳統黃芪的藥效;(2)本發明通過摸索獲得合適的濕法製粒工藝,使得製粒過程除了乙醇-水的加入之外,沒有引入其他任何添加劑,即可獲得固含量、黏度適中的軟材,以順利地進行擠壓成粒工藝,所形成的中藥顆粒穩定性強,貯存及運輸過程中不易崩爛;(3)本發明的擠壓條件摸索了合適的轉速和擠壓力,由此製成黏性、密度適中的黃芪顆粒製劑,在獲得成品穩定性強的同時,服用過程中又使其容易崩解分散,便於溫開水沖服。 Compared with the prior art, the present invention has the following beneficial effects: (1) The xanthine preparation obtained by the method of the invention has greatly improved utilization rate of active ingredients, and the utilization rate is close to 100%; it is confirmed by bioequivalence test that 1 is adopted. /4 parts of the Astragalus membranaceus breaking preparation can be equivalent to the efficacy of 1 part of traditional scutellaria; (2) The invention obtains a suitable wet granulation process by groping, so that the granulation process is not introduced except for the addition of ethanol-water. With any other additives, a soft material with a solid content and a moderate viscosity can be obtained to smoothly carry out the extrusion granulation process, and the formed Chinese medicinal particles have high stability and are not easily collapsed during storage and transportation; (3) The invention Extrusion conditions explored the appropriate rotation speed and extrusion force, thereby preparing a viscous, moderate-density scutellaria granule preparation, which is easy to disintegrate and disperse during the taking process, and is easy to warm water. Crushed.

為了能夠更清楚地理解本發明的技術內容,特舉以下實施例詳細說明,但本發明的實施方式不限於此。 In order to more clearly understand the technical content of the present invention, the following embodiments are specifically described, but the embodiments of the present invention are not limited thereto.

實施例1 Example 1

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液(乙醇品質分數為20%)濕法製軟材,溶液與超細粉體加入量比0.6:1(按重量計),混勻後,經預裝10目篩,選用擠壓轉速50r/min,擠壓力度1MPa製濕顆粒,濕顆粒轉置熱風迴圈烘箱中,設定乾燥溫度85℃,乾燥2.5h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, then ultrafinely pulverize into 90% of the ultrafine powder with a particle size of 45 μm or less, and add an ethanol-water solution (the ethanol quality fraction is 20%). Wet method soft material, the ratio of solution to ultrafine powder is 0.6:1 (by weight), after mixing, pre-loaded with 10 mesh sieve, select extrusion speed 50r/min, extrusion strength 1MPa to make wet particles The wet granules are transferred into a hot air loop oven, and the drying temperature is set at 85 ° C, dried for 2.5 h to dryness, and the whole granules are sieved to obtain a scutellaria scutellariae preparation.

實施例2 Example 2

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液(乙醇品質分數為40%)濕法製軟材,溶液與超細粉體加入量比0.9:1(按重量計),混勻後,經預裝10目篩,選用擠壓轉速70r/min,擠壓力度0.9MPa製濕顆粒,濕顆粒轉置真空微波乾燥箱中,設定乾燥溫度45℃,乾燥0.75h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, then ultrafinely pulverize into 90% of the ultrafine powder with a particle size of 45 μm or less, and add an ethanol-water solution (the ethanol quality fraction is 40%). Wet method soft material, the ratio of solution to ultrafine powder is 0.9:1 (by weight), after mixing, pre-loaded with 10 mesh sieve, using extrusion speed 70r/min, pressing force 0.9MPa The granules and wet granules were transferred into a vacuum microwave drying oven, and the drying temperature was set at 45 ° C, dried for 0.75 h to dryness, and the whole granules were sieved to obtain a scutellaria scutellariae preparation.

實施例3 Example 3

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液(乙醇品質分數為60%)濕法製軟材,溶液與超細粉體加入量比1.0:1(按重量計),混勻後,經預裝30目篩,選用擠壓轉速80r/min,擠壓力度0.3MPa製濕顆粒,濕 顆粒轉置熱風迴圈烘箱中,設定乾燥溫度85℃,乾燥2.5h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, then ultrafinely pulverize into 90% of the ultrafine powder with a particle size of 45 μm or less, and add an ethanol-water solution (the ethanol quality fraction is 60%). Wet method soft material, the ratio of solution to ultrafine powder is 1.0:1 (by weight), after mixing, pre-loaded with 30 mesh sieve, using extrusion speed 80r/min, pressing force 0.3MPa Granule, wet The granules are placed in a hot air loop oven, set to a drying temperature of 85 ° C, dried for 2.5 h to dryness, and the whole granules are sieved to obtain a scutellaria scutellariae preparation.

實施例4 Example 4

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液(乙醇品質分數為80%)濕法製軟材,溶液與超細粉體加入量比1.1:1(按重量計),混勻後,經預裝30目篩,選用擠壓轉速60r/min,擠壓力度0.6MPa製濕顆粒,濕顆粒轉置真空微波乾燥箱中,設定乾燥溫度50℃,乾燥0.5h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh. After ultrafine pulverization into 90% of the ultrafine powder, the powder with a particle size of 45 μm or less is added to the ethanol-water solution (the ethanol quality fraction is 80%). Wet method soft material, the ratio of solution to ultrafine powder is 1.1:1 (by weight), after mixing, pre-loaded with 30 mesh sieve, using extrusion speed of 60r/min, extrusion force of 0.6MPa The granules and the wet granules were transferred into a vacuum microwave drying oven, and the drying temperature was set at 50 ° C, dried for 0.5 h to dryness, and the whole granules were sieved to obtain a scutellariae broken wall preparation.

實施例5 Example 5

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液(乙品質分數為70%)濕法製軟材,溶液與超細粉體加入量比0.8:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速100r/min,擠壓力度0.05MPa製濕顆粒,濕顆粒轉置熱風迴圈風箱中,設定乾燥溫度70℃,乾燥2.0h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to about 100 mesh coarse powder, then pulverize it into ultrafine powder to 90% of the powder with particle size less than or equal to 45μm, and add ethanol-water solution (B quality score is 70) %) Wet method soft material, the ratio of solution to ultrafine powder is 0.8:1 (by weight), after mixing, pre-installed 20 mesh sieve, select extrusion speed 100r/min, extrusion force 0.05MPa The wet granules and the wet granules are transferred into the hot air circulation bellows, and the drying temperature is set to 70 ° C, dried for 2.0 h to dryness, and the whole granules are sieved to obtain the jaundice broken wall preparation.

實施例6 Example 6

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液的品質分數為40%的溶液濕法製軟材,溶液與超細粉體加入量比1.1:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速80r/min,擠壓力度0.2MPa製濕顆粒,採用沸騰乾燥,設定乾燥進風溫度85℃,乾燥1.0h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, and then pulverize it into ultrafine powder to 90% of the powder with a particle size of 45 μm or less. The mass fraction of the ethanol-water solution added is 40%. The solution is made of wet method, the ratio of solution to ultrafine powder is 1.1:1 (by weight). After mixing, pre-loaded with 20 mesh sieve, the extrusion speed is 80r/min, and the extrusion force is 0.2MPa. The wet granules are boiled and dried, set to dry air temperature of 85 ° C, dried for 1.0 h to dry, and the whole granules are sieved to obtain jaundice broken wall preparation.

實施例7 Example 7

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液(乙醇品質分數為20%)濕法製軟材,溶液與超細粉體加入量比0.7:1(按重量計),混勻後,經預裝10目篩,選用擠壓轉速50r/min,擠壓力度1MPa製濕顆粒,濕顆粒轉置熱風迴圈烘箱中,設定乾燥溫度85℃,乾燥2.5h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, then ultrafinely pulverize into 90% of the ultrafine powder with a particle size of 45 μm or less, and add an ethanol-water solution (the ethanol quality fraction is 20%). Wet method for soft material, the ratio of solution to ultrafine powder is 0.7:1 (by weight). After mixing, pre-loaded with 10 mesh sieve, select extrusion speed 50r/min, extrusion strength 1MPa to make wet particles. The wet granules are transferred into a hot air loop oven, and the drying temperature is set at 85 ° C, dried for 2.5 h to dryness, and the whole granules are sieved to obtain a scutellaria scutellariae preparation.

實施例8 Example 8

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液的品質分數為30%的溶液濕法製軟材,溶液與超細粉體加入量比0.65:1(按重量計),混 勻後,經預裝20目篩,選用擠壓轉速65r/min,擠壓力度0.7MPa製濕顆粒,採用沸騰乾燥,設定乾燥進風溫度85℃,乾燥1.0h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, and then pulverize it into ultrafine powder to 90% of the powder with a particle size of 45 μm or less. The mass fraction of the ethanol-water solution added is 30%. The solution is made of wet method, and the ratio of solution to ultrafine powder is 0.65:1 (by weight). After uniformization, pre-installed 20 mesh sieve, select the extrusion speed 65r/min, the extrusion strength 0.7MPa wet particles, use boiling drying, set the dry inlet air temperature 85 ° C, dry 1.0h to dry, after the whole sieve That is, the yellow sputum broken wall preparation.

實施例9 Example 9

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液的品質分數為50%的溶液濕法製軟材,溶液與超細粉體加入量比0.8:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速85r/min,擠壓力度0.5MPa製濕顆粒,採用沸騰乾燥,設定乾燥進風溫度85℃,乾燥1.0h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, and then pulverize it into ultrafine powder to 90% of the powder with a particle size of 45 μm or less. The mass fraction of the ethanol-water solution added is 50%. The solution is made of wet method, and the ratio of solution to ultrafine powder is 0.8:1 (by weight). After mixing, pre-loaded with 20 mesh sieve, the extrusion speed is 85r/min, and the extrusion force is 0.5MPa. The wet granules are boiled and dried, set to dry air temperature of 85 ° C, dried for 1.0 h to dry, and the whole granules are sieved to obtain jaundice broken wall preparation.

實施例10 Example 10

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液(乙醇品質分數為80%)濕法製軟材,溶液與超細粉體加入量比1.3:1(按重量計),混勻後,經預裝30目篩,選用擠壓轉速50r/min,擠壓力度0.8MPa製濕顆粒,濕顆粒轉置真空微波乾燥箱中,設定乾燥溫度50℃,乾燥0.5h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh. After ultrafine pulverization into 90% of the ultrafine powder, the powder with a particle size of 45 μm or less is added to the ethanol-water solution (the ethanol quality fraction is 80%). Wet method soft material, the ratio of solution to ultrafine powder is 1.3:1 (by weight), after mixing, pre-loaded with 30 mesh sieve, select extrusion speed 50r/min, extrusion force 0.8MPa to make wet The granules and the wet granules were transferred into a vacuum microwave drying oven, and the drying temperature was set at 50 ° C, dried for 0.5 h to dryness, and the whole granules were sieved to obtain a scutellariae broken wall preparation.

備註:滿分以10計。 Remarks: The full score is 10.

實施例11 Example 11

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液(乙醇品質分數為80%)濕法製軟材,溶液與超細粉體加入量比1.3:1(按重量計),混勻後,經預裝30目篩,選用擠壓轉速70r/min,擠壓力度1.0MPa製濕顆粒,濕顆粒轉置真空微波乾燥箱中,設定乾燥溫度50℃,乾燥0.5h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh. After ultrafine pulverization into 90% of the ultrafine powder, the powder with a particle size of 45 μm or less is added to the ethanol-water solution (the ethanol quality fraction is 80%). Wet method for making soft materials, the ratio of solution to ultrafine powder is 1.3:1 (by weight), after mixing, pre-loaded with 30 mesh sieve, using extrusion speed of 70r/min, extrusion force of 1.0MPa The granules and the wet granules were transferred into a vacuum microwave drying oven, and the drying temperature was set at 50 ° C, dried for 0.5 h to dryness, and the whole granules were sieved to obtain a scutellariae broken wall preparation.

實施例12 Example 12

取黃芪淨藥材,經粗粉碎至100目左右粗粉後,經超微粉碎粉碎成超細粉體中90%的顆粒粒徑小於等於45μm的粉體,加入乙醇-水溶液的品質分數為25%的溶液濕法製軟材,溶液與超細粉體加入量比0.65:1(按重量計),混勻後,經預裝20目篩,選用擠壓轉速100r/min,擠壓力度0.03MPa製濕顆粒,採用沸騰乾燥,設定乾燥進風溫度85℃,乾燥1.0h至乾,整粒篩分後即得黃芪破壁製劑。 Take the Astragalus membranaceus medicinal material and coarsely pulverize it to a coarse powder of about 100 mesh, and then pulverize it into ultrafine powder to 90% of the powder with a particle size of 45 μm or less. The mass fraction of the ethanol-water solution added is 25%. The solution is made of wet method, and the ratio of solution to ultrafine powder is 0.65:1 (by weight). After mixing, pre-loaded with 20 mesh sieve, the extrusion speed is 100r/min, and the extrusion force is 0.03MPa. The wet granules are boiled and dried, set to dry air temperature of 85 ° C, dried for 1.0 h to dry, and the whole granules are sieved to obtain jaundice broken wall preparation.

實施例13 Example 13

取實施例1~5、8~9項下成品按成品品質標準檢驗,結果均符合中國藥典相關劑型項下規定要求,結果如表1所示。 The finished products of Examples 1~5 and 8~9 were tested according to the finished product quality standards, and the results were all in accordance with the requirements of the relevant Chinese Pharmacopoeia related dosage forms. The results are shown in Table 1.

進一步將實施例1~5、8~9項下黃芪破壁製劑與黃芪超細粉體、黃芪常規飲片,以性狀、水分和有效成分黃芪甲苷作為評價指標,三者均採用密封塑膠袋封裝後放置在溫度40℃±2℃,相對濕度75%±5%的條件下放置30天、60天、90天后評價各個製劑穩定性。結果如下表: Further, the scutellaria scutellariae preparations of Example 1~5, 8~9, and the traditional scutellariae of Astragalus membranaceus and Astragalus membranaceus were used as indicators for evaluation of traits, water and active ingredient Astragaloside IV, all of which were sealed in sealed plastic bags. Thereafter, the stability of each preparation was evaluated after being placed at a temperature of 40 ° C ± 2 ° C and a relative humidity of 75% ± 5% for 30 days, 60 days, and 90 days. The results are as follows:

由上表可以看出,本發明製備得到的黃芪破壁製劑中水分含量在不同時期十分穩定,而黃芪超微粉體中的水分含量在不同時期變化較大,說明黃芪超微粉體吸濕性較強。由於黃芪超微粉體易吸濕,使得超微粉體中容易滋生細菌,這樣會導致有效成分加快分解,上表中黃芪甲苷的含量下降也證明了黃芪超細粉體有效成分易分解。當利用本發明方法製成黃芪破壁製劑後,其中水分含量十分穩定,不容易吸濕,與黃芪超細粉體相比,其穩定性大大提高。 It can be seen from the above table that the moisture content of the Huangqi broken wall preparation prepared by the invention is very stable in different periods, and the moisture content in the ultrafine powder of Astragalus membranaceus varies greatly in different periods, indicating that the yellow peony ultrafine powder absorbs moisture. Stronger. Because the ultrafine powder of Astragalus membranaceus is easy to absorb moisture, it is easy to breed bacteria in the ultrafine powder, which will lead to accelerated decomposition of the active ingredient. The decrease of the content of astragaloside IV in the above table also proves that the active ingredient of the astragalus ultrafine powder is easily decomposed. When the method of the present invention is used to prepare the scutellariae breaking preparation, the moisture content thereof is very stable, and it is not easy to absorb moisture, and the stability is greatly improved compared with the scutellaria ultrafine powder.

實施例14 Example 14

以下再一步通過急性毒性和藥效對比實驗說明本發明的先進性,取實施例3製得的黃芪製劑與傳統飲片比較。 In the following step, the advanced nature of the present invention is demonstrated by an acute toxicity and efficacy comparison experiment, and the astragalus preparation prepared in Example 3 is compared with a conventional decoction piece.

一、急性毒性試驗 First, acute toxicity test

KM種小鼠,60只,雌雄各半,隨機分為對照組、黃芪常規飲片組(32g/kg體重)、黃芪破壁製劑組(32g/kg體重)。 KM mice, 60 male and female, were randomly divided into control group, Huangqi conventional decoction group (32g/kg body weight) and Huangqi broken wall preparation group (32g/kg body weight).

表1、2結果表明黃芪常規飲片、黃芪破壁製劑對小鼠灌胃一日最大給藥量為32g/kg體重,相當於臨床用量的64倍,均無明顯急性毒性產生。 The results in Tables 1 and 2 indicate that the maximum daily dose of Huangqi Traditional Decoction Pieces and Astragalus membranaceus Broken Preparations on mice was 32g/kg body weight, which is equivalent to 64 times of clinical dose, and no obvious acute toxicity was produced.

表1結果顯示,黃芪破壁製劑組、黃芪水煎液組動物體重增長與對照組比較無顯著性差異(P>0.05)。 The results in Table 1 showed that there was no significant difference in weight gain between the Astragalus membranaceus group and the Astragalus membranaceus group (P>0.05).

表2結果顯示,黃芪破壁製劑組、黃芪水煎液組動物動物各臟器指數與對照組比較均無顯著性差異(P>0.05)。 The results in Table 2 showed that there was no significant difference in the index of the animals in the Astragalus membranaceus group and the Astragalus membranaceus group compared with the control group (P>0.05).

二、藥效學比較 Second, pharmacodynamic comparison

取SPF級KM種小鼠,雌雄各半,體重18-22g,隨機分為正常對照組、模型對照組、生脈膠囊組、黃芪傳統飲片組(傳統煎煮方式、灌胃)、黃芪破壁製劑0.25g/kg組、黃芪破壁製劑0.5g/kg組、黃芪破壁製劑1.0g/kg組、黃芪破壁製劑2.0g/kg組,每組10只。破壁製劑組是將實施例3製得的製劑放置90天之後,以60°左右的溫開水沖調,取上清液灌胃給藥。 SPF-class KM mice, male and female, weighing 18-22g, were randomly divided into normal control group, model control group, Shengmai capsule group, Huangqi traditional decoction group (traditional decoction method, gavage), and jaundice broken wall. The preparations were 0.25g/kg group, Huangqi broken wall preparation 0.5g/kg group, Huangqi broken wall preparation 1.0g/kg group, and Huangqi broken wall preparation 2.0g/kg group, 10 groups in each group. In the broken wall preparation group, after the preparation prepared in Example 3 was allowed to stand for 90 days, it was prepared by applying warm water of about 60°, and the supernatant was administered by intragastric administration.

表3、4結果表明黃芪破壁粉的藥效作用優於黃芪常規飲片,相當於1/8量。 The results in Tables 3 and 4 indicate that the pharmacodynamic effect of Astragalus membranaceus breaks is better than that of Astragalus membranaceus, which is equivalent to 1/8.

Claims (9)

一種黃芪破壁製劑,其特徵在於,將黃芪進行破壁粉碎獲得超細粉體,加入乙醇-水溶液製軟材,再進一步擠壓獲得濕粒,乾燥獲得黃芪破壁製劑;所述超細粉體中90%或以上的顆粒粒徑小於等於45μm。 A yellow scorpion broken wall preparation characterized in that the scutellaria is subjected to wall pulverization to obtain an ultrafine powder, and an ethanol-water solution is added to prepare a soft material, and further extruded to obtain wet granules, and dried to obtain a scutellaria broken preparation; the ultrafine powder 90% or more of the particles in the body have a particle diameter of 45 μm or less. 根據請求項1所述的黃芪破壁製劑,其特徵在於,所述的乙醇-水溶液中乙醇的品質分數為20%~80%。 The jaundice breaking preparation according to claim 1, wherein the ethanol-water solution has a quality fraction of ethanol of 20% to 80%. 根據請求項1所述的黃芪破壁製劑,其特徵在於,所述的超細粉體與乙醇-水溶液品質比為1:0.6~1.3。 The jaundice breaking preparation according to claim 1, characterized in that the quality ratio of the ultrafine powder to the ethanol-water solution is 1:0.6 to 1.3. 根據請求項1所述的黃芪破壁製劑,其特徵在於,當乙醇品質分數為20%~29%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~0.65;當乙醇品質分數為30%~39%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~0.9;當乙醇品質分數為40%~49%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~1.0;當乙醇品質分數為50%~59%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~1.1;當乙醇品質分數為60%~69%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~1.2;當乙醇品質分數為70%~80%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~1.3。 The jaundice breaking preparation according to claim 1, characterized in that, when the ethanol quality fraction is 20% to 29%, the ratio of the ultrafine powder to the ethanol-water solution is 1:0.6 to 0.65 by weight; When the fraction is 30%~39%, the ratio of ultrafine powder to ethanol-water solution is 1:0.6~0.9; when the ethanol quality fraction is 40%~49%, the ratio of ultrafine powder to ethanol-water solution is compared. The weight is 1:0.6~1.0; when the ethanol quality fraction is 50%~59%, the ratio of ultrafine powder to ethanol-water solution is 1:0.6~1.1 by weight; when the ethanol quality score is 60%~69% When the ratio of the ultrafine powder to the ethanol-water solution is 1:0.6 to 1.2 by weight; when the ethanol quality fraction is 70% to 80%, the ratio of the ultrafine powder to the ethanol-water solution is 1:0.6 by weight. 1.3. 根據請求項4所述的黃芪破壁製劑,其特徵在於,當乙醇品質分數為20%~29%時,超細粉體與乙醇-水溶液比按重量計為1:0.6;當乙醇品質分數為30%~39%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~0.65;當乙醇品質分數為40%~49%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~0.7;當乙醇品質分數為50%~59%時,超細粉體與乙醇-水溶液比按重量計為1:0.6~0.8;當乙醇品質分數為60%~69%時,超細粉體與乙醇-水溶液比按重量計為1:0.8~1.0,當 乙醇品質分數為70%~80%時,超細粉體與乙醇-水溶液比按重量計為1:0.8~1.1。 The scutellaria breaking preparation according to claim 4, wherein when the ethanol quality fraction is 20% to 29%, the ratio of the ultrafine powder to the ethanol-water solution is 1:0.6 by weight; when the ethanol quality fraction is When 30%~39%, the ratio of ultrafine powder to ethanol-water solution is 1:0.6~0.65; when the ethanol quality fraction is 40%~49%, the ratio of ultrafine powder to ethanol-water solution is by weight. 1:0.6~0.7; when the ethanol quality fraction is 50%~59%, the ratio of ultrafine powder to ethanol-water solution is 1:0.6~0.8 by weight; when the ethanol quality score is 60%~69%, The ratio of ultrafine powder to ethanol-water solution is 1:0.8~1.0 by weight. When the ethanol quality fraction is 70% to 80%, the ratio of the ultrafine powder to the ethanol-water solution is 1:0.8 to 1.1 by weight. 根據請求項1所述的黃芪破壁製劑,其特徵在於,所述的黃芪破壁製劑的堆密度為0.30g/ml~0.65g/ml。 The jaundice breaking preparation according to claim 1, wherein the scutellaria breaking preparation has a bulk density of 0.30 g/ml to 0.65 g/ml. 根據請求項1所述的黃芪破壁製劑,其特徵在於,所述的擠壓條件為:濕法製粒:預裝篩網目數為10目~30目,擠壓力度0.05Mpa~1Mpa,轉速50r/min~100r/min。 The scutellaria breaking preparation according to claim 1, characterized in that the extrusion condition is: wet granulation: the number of pre-loaded sieve meshes is 10 mesh to 30 mesh, the pressing force is 0.05 Mpa to 1 Mpa, and the rotational speed is 50 r. /min~100r/min. 根據請求項7所述的黃芪破壁製劑,其特徵在於,所述的擠壓條件為:濕法製粒:擠壓力度0.7Mpa~0.8Mpa,轉速55r/min~65r/min。 The jaundice broken wall preparation according to claim 7, wherein the extrusion condition is: wet granulation: a pressing force of 0.7 Mpa to 0.8 MPa, and a rotation speed of 55 r/min to 65 r/min. 根據請求項1所述的黃芪破壁製劑,其特徵在於,擠壓所得的濕粒粒徑為14目~30目,乾燥時乾燥溫度為45℃~85℃,乾燥時間為0.5h~4.0h。 The scutellaria breaking preparation according to claim 1, characterized in that the wet particle size obtained by extrusion is 14 mesh to 30 mesh, the drying temperature during drying is 45 ° C to 85 ° C, and the drying time is 0.5 h to 4.0 h. .
TW103110194A 2013-03-20 2014-03-19 A preparation method of astragalus breaking preparation TWI531387B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310089961.XA CN104055832B (en) 2013-03-20 2013-03-20 A kind of Radix Astragali broken wall preparation

Publications (2)

Publication Number Publication Date
TW201436818A true TW201436818A (en) 2014-10-01
TWI531387B TWI531387B (en) 2016-05-01

Family

ID=51543951

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103110194A TWI531387B (en) 2013-03-20 2014-03-19 A preparation method of astragalus breaking preparation

Country Status (3)

Country Link
CN (1) CN104055832B (en)
HK (1) HK1201161A1 (en)
TW (1) TWI531387B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106924291A (en) * 2017-03-28 2017-07-07 王全理 For mineral drug or the processing method of shell Chinese medicine

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106265870A (en) * 2016-08-08 2017-01-04 湖南盟合投资管理有限公司 The preparation method of Radix Astragali breaking cellular wall decoction pieces
CN106265873A (en) * 2016-08-25 2017-01-04 刘根喜 A kind of Radix Astragali pure powder tablet and preparation method thereof
CN108310056B (en) * 2018-04-25 2020-11-03 中山市中智药业集团有限公司 Preparation method of no-additive traditional Chinese medicinal material wall-broken powder granular preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101147746B (en) * 2006-09-18 2011-02-16 中山市中智药业集团有限公司 Method for processing traditional Chinese herbs broken wall powder

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106924291A (en) * 2017-03-28 2017-07-07 王全理 For mineral drug or the processing method of shell Chinese medicine
CN106924291B (en) * 2017-03-28 2020-11-03 王全理 Treatment method for mineral medicine or shell type traditional Chinese medicine

Also Published As

Publication number Publication date
CN104055832B (en) 2018-03-16
TWI531387B (en) 2016-05-01
CN104055832A (en) 2014-09-24
HK1201161A1 (en) 2015-08-28

Similar Documents

Publication Publication Date Title
CN102631377B (en) Cordyceps sinensis freeze-dried nano powder tablet and preparation method thereof
TWI531387B (en) A preparation method of astragalus breaking preparation
TWI549700B (en) Panax notoginseng broken wall preparation
TWI566785B (en) A preparation method of Dendrobium broken
TWI530302B (en) A method for preparing salvia miltiorrhiza and its preparation
TWI508752B (en) A preparation method of chrysanthemum broken wall preparation
CN100384405C (en) Hepatitis B support right fast dispersion solid preparation and its preparation method
CN100384404C (en) Jinsuo emission-arresting fast dispersing solid preparation and its preparation method
CN104055825B (en) A kind of Radix Codonopsis broken wall preparation
CN104055835B (en) A kind of beautiful millettia root broken wall preparation
CN102120016B (en) Method for preparing Sichuan fritillary bulb and fructus momordicae cough relieving tablets
TWI501787B (en) A preparation method of American ginseng broken wall preparation
CN100384401C (en) Kunbao (female treasure) fast dispersion solid preparation and its preparation method
CN104055814A (en) Preparation method of American ginseng wall-broken preparation
CN104055820A (en) Saussurea involucrate wall-broken preparation
CN102670920B (en) Good-health traditional Chinese medicine preparation with improved stability
CN104055815B (en) A kind of red ginseng broken wall preparation
CN100515406C (en) Macaque stone bovinebezoar fast dispersion solid preparation and its preparation method
JP7158831B2 (en) Tablet containing goshitsu processed material
CN104055809B (en) A kind of Radix Angelicae Sinensis broken wall preparation
CN104055826B (en) A kind of rhodiola root broken wall preparation
CN100486564C (en) Jinkui kidney qi fast dispersion solid preparation and its preparation method
CN100515403C (en) Yangkun fast dispersion solid preparation for female and its preparation method
CN104055857A (en) Cistanche wall-broken preparation
CN104055806A (en) Wall-broken Chinese yew preparation